Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
479.5(c) 493.5(c) 501(c) 505(c) 524(c) Last
1 852 3 898 3 639 2 274 5 259 Volume
-1.03% +2.92% +1.52% +0.80% +3.76% Change
More quotes
Estimated financial data (e)
Sales 2021 3 366 M 3 994 M 3 994 M
Net income 2021 418 M 495 M 495 M
Net Debt 2021 1 872 M 2 221 M 2 221 M
P/E ratio 2021 92,8x
Yield 2021 0,24%
Sales 2022 3 693 M 4 382 M 4 382 M
Net income 2022 475 M 564 M 564 M
Net Debt 2022 1 566 M 1 858 M 1 858 M
P/E ratio 2022 83,9x
Yield 2022 0,26%
Capitalization 35 364 M 41 951 M 41 967 M
EV / Sales 2021 11,1x
EV / Sales 2022 10,0x
Nbr of Employees 11 981
Free-Float 36,2%
More Financials
Company
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers... 
More about the company
Ratings of Sartorius AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about SARTORIUS AG
07/29SARTORIUS VORZUEGE : DZ Bank gives a Neutral rating
MD
07/29SARTORIUS : Snaps Up German Cell Culture Company Xell
MT
07/28SARTORIUS VORZUEGE : Gets a Neutral rating from NorldLB
MD
07/27SARTORIUS VORZUEGE : UBS keeps a Sell rating
MD
07/27SARTORIUS VORZUEGE : Berenberg reiterates its Neutral rating
MD
07/26SARTORIUS VORZUEGE : Gets a Buy rating from JP Morgan
MD
07/21SARTORIUS VORZUEGE : JP Morgan keeps its Buy rating
MD
07/21SARTORIUS VORZUEGE : Sell rating from UBS
MD
07/21SARTORIUS VORZUEGE : Gets a Buy rating from Warburg Research
MD
07/21SARTORIUS : Financial Data H1|2021
PU
07/21SARTORIUS : Life Sciences Group Sartorius' Profit Soars 109% in H1 on Sustained ..
MT
07/21Sartorius Aktiengesellschaft Reaffirms Earnings Guidance for the Year 2021
CI
07/21Sartorius Aktiengesellschaft Reports Earnings Results for the Second Quarter ..
CI
07/06SARTORIUS VORZUEGE : UBS remains a Sell rating
MD
07/06SARTORIUS VORZUEGE : Warburg Research reiterates its Buy rating
MD
More news
News in other languages on SARTORIUS AG
07/29SARTORIUS : übernimmt den Zellkulturspezialisten Xell AG
07/21MÄRKTE EUROPA/Erholung gewinnt an Dynamik
07/21XETRA-SCHLUSS/Kräftig erholt - nur SAP kann den DAX bremsen
07/21MÄRKTE EUROPA/Nur SAP bremst die DAX-Erholung
07/21MÄRKTE EUROPA/Börsen bauen Gewinne aus - SAP fallen
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Stock Trading Strategies
SARTORIUS AG - 07/28
No turn-around in sight
BUY
More Stock Trading Analysis
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | SRT | DE0007165607 | MarketScreener
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 524,00 €
Average target price 382,92 €
Spread / Average Target -26,9%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG51.88%41 951
REVENIO GROUP OYJ35.98%2 156
BIOTAGE AB (PUBL)77.27%1 868
CELLAVISION AB (PUBL)47.69%1 257
VAREX IMAGING CORPORATION63.67%1 073
ANGLE PLC128.80%356